BioNTech Eyes Morocco for Potential mRNA Vaccine Factory in Africa Expansion

The German biotech company - which is behind the vaccine developed with Pfizer - has unveiled part of its expansion plan aimed at creating a large factory for the production of innovative medicines in Africa. According to its CEO, Ugur Sahin, the German firm is considering building a factory in Africa and developing a manufacturing network with local partners to transfer its mRNA-based technology - a genetic molecule - to a continent that suffers from a lack of access to vaccines and other vital treatments, reports The Wall Street Journal.

To read:

In its sights are five African countries that have a vaccine industry. These are Morocco, Egypt, South Africa, Tunisia and Senegal. The German firm intends to negotiate the possibilities of opening the factory in one of these countries.